Mr. Jonathan Noel

Mr. Jonathan Noel
Mr Jonathan Noël, MBBS (UWI) FRCS (Urol) is a double robotic surgical fellowship trained urologist. He has developed expertise in radical prostatectomy techniques from the Royal Marsden (anterior retzius spare) and the Lister Hospital (NeuroSAFE: neurovascular structure adjacent frozen section examination). Mr Noël went further to advance his robotic prostate surgery in Florida, USA. He is the only UK surgeon to receive formalised mentorship from Professor Vipul Patel, and this has enhanced his surgical foundation from the Royal College of Surgeons of England. He has high volume and complex case experience; along with the diversity of patient interface, working in three health care systems across the globe. These have allowed Mr Noël a fusion of management approaches, guided by his international portfolio. His developing research portfolio includes analysis of emerging robotic systems, augmented reality and artificial intelligence platforms. Mr Noël has adopted the semi autonomous robotic approach of Aquablation for benign prostate obstruction. He keeps his focus on improving patient's experience and their outcomes after surgery. Mr Noël is a Consultant at Guy’s & St Thomas’ NHS Foundation Trust, a globally recognised institute in robotic surgery. Mr Noël is also the director of the Global Robotic Prostate, through which he offers private surgical services.
Medical School:

University of the West Indies


North London Deanery


Global Robotics Institute, Florida, US.

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only